Synthelabo presents in vitro, ex vivo and in vivo data on new MAO-B inhibitor Nov. 11, 1998 No Comments
LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner Nov. 11, 1998 No Comments
Nonpeptide CRF1 antagonist developed at Parke-Davis modulates brain NE levels Nov. 11, 1998 No Comments
Knoll develops potential new antipsychotic agent with advantages over available therapies Nov. 10, 1998 No Comments
LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects Nov. 10, 1998 No Comments
NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain Nov. 10, 1998 No Comments
Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy Nov. 10, 1998 No Comments
Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week Nov. 10, 1998 No Comments
RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist Nov. 10, 1998 No Comments
Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist Nov. 10, 1998 No Comments